financetom
Market
financetom
/
Market
/
Sudarshan Sukhani on January 15: Buy HDFC Bank, Reliance Industries, & Asian Paints
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sudarshan Sukhani on January 15: Buy HDFC Bank, Reliance Industries, & Asian Paints
Jan 15, 2019 12:02 AM

The latest analysis and commentary by stock market guru Sudarshan Sukhani on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Bata India, NIIT Technologies, RBL Bank, Ajanta Pharma, Vedanta, Yes Bank, HDFC Bank, Reliance Industries, Asian Paints, Jet Airways, Zee Entertainment, Page Industries.

“Consider buying HDFC Bank. It is leading the banks. Consider buying Reliance Industries, same reason, it is leading the Nifty. Consider buying Asian Paints which is recovering from a small dip and also the lower crude is helping it,” he said.

“Given the fact that we are all in an upbeat mood today, we should be buying midcaps. The largecaps are taken care of by the indices. So start with Bata India. It is making new highs again. I think there is significant up move left here. That is a buy. NIIT Technologies finally confirmed an extremely attractive and bullish pattern yesterday. That is a perfect bullish head and shoulder. So, NIIT Technologies is a buy for the day; it is a positional trade. RBL Bank which is inside a consolidation and outperforming the other private sector banks, I have no idea what it does and why, but he charts are excellent. That is a buy. Ajanta Pharma which keeps on coming in my buy list is outperforming everything else. There are 4 different buys from 4 different sectors, just to temper it, all metals are short sells and that is Vedanta for the day. However, keep the short sell only intraday,” he added.

Follow stock recommendations by Sudarshan Sukhani here:

https://www.cnbctv18.com/author/sudarshan-sukhani-159/

Disclaimer: Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

First Published:Jan 15, 2019 9:02 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Datadog Insider Sold Shares Worth $4,292,337, According to a Recent SEC Filing
Datadog Insider Sold Shares Worth $4,292,337, According to a Recent SEC Filing
Aug 13, 2025
04:38 PM EDT, 08/13/2025 (MT Newswires) -- Olivier Pomel, Director and Chief Executive Officer, on August 11, 2025, sold 32,923 shares in Datadog ( DDOG ) for $4,292,337. Following the Form 4 filing with the SEC, Pomel has control over a total of 548,715 Class A common shares of the company, with 548,715 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1561550/000156155025000224/xslF345X05/wk-form4_1755117085.xml ...
Xeris Biopharma Holdings Insider Sold Shares Worth $309,226, According to a Recent SEC Filing
Xeris Biopharma Holdings Insider Sold Shares Worth $309,226, According to a Recent SEC Filing
Aug 13, 2025
04:53 PM EDT, 08/13/2025 (MT Newswires) -- Dawn Halkuff, Director, on August 12, 2025, sold 42,500 shares in Xeris Biopharma Holdings ( XERS ) for $309,226. Following the Form 4 filing with the SEC, Halkuff has control over a total of 120,410 common shares of the company, with 115,000 shares held directly and 5,410 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000138/xslF345X05/wk-form4_1755118058.xml ...
Amneal Pharmaceuticals Insider Sold Shares Worth $302,596, According to a Recent SEC Filing
Amneal Pharmaceuticals Insider Sold Shares Worth $302,596, According to a Recent SEC Filing
Aug 13, 2025
04:42 PM EDT, 08/13/2025 (MT Newswires) -- Andrew S Boyer, Executive Vice President, on August 12, 2025, sold 33,436 shares in Amneal Pharmaceuticals ( AMRX ) for $302,596. Following the Form 4 filing with the SEC, Boyer has control over a total of 256,670 Class A common shares of the company, with 256,670 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1723128/000172312825000048/xslF345X05/wk-form4_1755117489.xml ...
US Equity Indexes Rise as Bessent Reportedly Open to 50 Basis Point Fed Rate Cut in September
US Equity Indexes Rise as Bessent Reportedly Open to 50 Basis Point Fed Rate Cut in September
Aug 13, 2025
04:31 PM EDT, 08/13/2025 (MT Newswires) -- US equity indexes rose on Wednesday, with the Dow Jones Industrial Average climbing over 463 points, as a drop in government bond yields and the dollar helped validate a strong probability that the Federal Reserve will cut interest rates in September. The Nasdaq was up 0.1% to 21,713.14, extending gains from Tuesday, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved